The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 7, 2012, Pages 928-933

  Seddon, James Alexander ^a,b   Hesseling, A C ^a   Marais, B J ^c,d   Jordaan, A ^a   Victor, T ^a   Schaaf, H S ^a,e  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

DST; Paediatric; Resistant; Surveillance; TB

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; QUINOLONE DERIVATIVE; RIFAMPICIN;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DRUG RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; EPIDEMIC; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANCE; MYCOBACTERIUM; PEDIATRICS; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COINFECTION; EPIDEMICS; ETHAMBUTOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RIFAMPIN; SOUTH AFRICA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84862233071     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0679     Document Type: Article

References (26)

1. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.
2. Marais B J, Victor T C, Hesseling A C, et al. Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol 2006; 44: 3539-3543. (Pubitemid 46768796)
3. Schaaf H S, Gie R P, Kennedy M, Beyers N, Hesseling P B, Donald P R. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics 2002; 109: 765-771. (Pubitemid 34493340)
4. Snider D E Jr, Kelly G D, Cauthen G M, Thompson N J, Kilburn J O. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis 1985; 132: 125-132. (Pubitemid 15026199)
5. Teixeira L, Perkins M D, Johnson J L, et al. Infection and disease among household contacts of patients with multidrugr esistant tuberculosis. Int J Tuberc Lung Dis 2001; 5: 321-328. (Pubitemid 32397582)
6. van Rie A, Warren R, Richardson M, et al. Exogenous rei nfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341: 1174-1179. (Pubitemid 29480655)
7. Schaaf H S, Van Rie A, Gie R P, et al. Transmission of multidrug-resistant tuberculosis. Pediatr Infect Dis J 2000; 19: 695-699. (Pubitemid 30644036)
8. Steiner P, Rao M, Mitchell M, Steiner M. Primary drug-resistant tuberculosis in children. Correlation of drug-susceptibility patterns of matched patient and source case strains of Mycobacterium tuberculosis. Am J Dis Child 1985; 139: 780-782. (Pubitemid 15022971)
9. Schaaf H S, Gie R P, Beyers N, Sirgel F A, de Klerk P J, Donald P R. Primary drug-resistant tuberculosis in children. Int J Tuberc Lung Dis 2000; 4: 1149-1155. (Pubitemid 32046293)
10. Schaaf H S, Marais B J, Hesseling A C, Gie R P, Beyers N, Donald P R. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr 2006; 95: 523-528. (Pubitemid 43791572)
11. Schaaf H S, Marais B J, Hesseling A C, Brittle W, Donald P R. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa-an upward trend. Am J Public Health 2009; 99: 1486-1490.
12. Kassa-Kelembho E, Bobossi-Serengbe G, Takeng E C, Nambea-Koisse T B, Yapou F, Talarmin A. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis 2004; 8: 574-578. (Pubitemid 38625062)
13. Health Systems Trust. South African health review 2010. Reported cases of TB (all types) (per 100 000). Pretoria, South Africa: HST, 2010. http://www.healthlink.org.za/uploads/files/sahr10-begin.pdf Accessed April 2012.
14. Averting HIV and AIDS. South African HIV & AIDS statistics. Horsham, UK: AVERT, 2011. http://www.avert.org/safricastats.htm Accessed February 2012.
15. Warren R M, Gey van Pittius N C, Barnard M, et al. Differentiation of Mycobacterium tuberculosis complex by PCR amplifi cation of genomic regions of difference. Int J Tuberc Lung Dis 2006; 10: 818-822. (Pubitemid 44031399)
16. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, nocardiae and other aerobic actinomycetes: approved standard. NCCLS document M24-A. Wayne, Pennysylvania, USA: NCCLS, 2003.
17. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792. (Pubitemid 351490566)
18. Marais B J, Gie R P, Schaaf H S, et al. A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 2004; 34: 886-894. (Pubitemid 39462398)
19. World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. WHO/HTM/TB/2006.371. WHO/FCH/CAH/2006.7. Geneva, Switzerland: WHO, 2006.
20. Schaaf H S, Marais B J. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Paediatr Respir Rev 2011; 12: 31-38.
21. Al-Dabbagh M, Lapphra K, McGloin R, et al. Drug-resistant tuberculosis: pediatric guidelines. Pediatr Infect Dis J 2011; 30: 501-505.
22. Louw G E, Warren R M, Donald P R, et al. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis 2006; 10: 802-807. (Pubitemid 44031396)
23. Johnson R, Jordaan A M, Pretorius L, et al. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 2006; 10: 68-73. (Pubitemid 43266280)
24. Hoek K G, Schaaf H S, Gey van Pittius N C, van Helden P D, Warren R M. Resistance to pyrazinamide and ethambutol compromises MDR/XDR-TB treatment. S Afr Med J 2009; 99: 785-787.
25. Vilcheze C, Weisbrod T R, Chen B, et al. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrob Agents Chemother 2005; 49: 708-720. (Pubitemid 40175684)
26. Hesseling A C, Schaaf H S, Victor T, et al. Resistant Mycobacterium bovis bacillus Calmette-Guerin disease: implications for management of bacillus Calmette-Guerin disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2004; 23: 476-479. (Pubitemid 38621494)